Merck: Court rejected its claim over allergy drug
19:36 EDT 15 Jun 2012 | Advantage Business Media
WHITEHOUSE STATION, N.J. (AP) — Merck & Co. said Friday that a federal judge rejected its patent infringement claim against Canadian generic drugmaker Apotex over its bid to make a version of Nasonex, a nasal allergy treatment Merck sells.Nasonex,..
Original Article: Merck: Court rejected its claim over allergy drug
More From BioPortfolio on "Merck: Court rejected its claim over allergy drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
